| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Albertsson, Maria, et al.
(författare)
-
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
- 2007
-
Ingår i: Medical Oncology. - : Springer Science and Business Media LLC. - 1357-0560 .- 1559-131X. ; 24:4, s. 407-412
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The purpose of these studies was to compare efficacy and toxicity of docetaxel alone with the combination of gemcitabine and docetaxel for treatment of metastatic esophageal carcinoma. PATIENTS AND METHODS: These studies enrolled patients with histopathologically verified squamous cell carcinoma or adenocarcinoma of the esophagus or cardia. Between March 1997 and June 1999, 52 patients were enrolled in the initial Phase II study (Study 1). They were scheduled for treatment with docetaxel 100 mg/m2 every third week as a 1-h infusion. The second Phase II study between September 2000 and March 2003 included 65 patients (Study II). They were given docetaxel 30 mg/m2, administered as a 30-min i.v. infusion weekly for four times, followed by 2 weeks of rest, and gemcitabine starting with a dose of 750 mg/m2 (if well-tolerated 1,000 mg/m2) on days 1 and 15, followed by 3 weeks of rest. A new cycle began on day 36. Patients were premedicated with betamethasone 8 mg p.o. on the evening before, and 8 mg i.v. 30-60 min before the docetaxel infusion. Response was confirmed by computed tomography and assessed at 12 and 24 weeks. Toxicity was assessed according to WHO scales. RESULTS: In study I, 38 out of the 52 enrolled patients were valuable. Two patients experienced complete remission (CR) (5%), 10 patients partial remission (PR) (26%), nine patients stable disease (SD) (24%), and 17 patients showed progressive disease (PD) (45%). Toxicity mainly involved leukopenia, which in some cases required hospitalization and treatment with antibiotics. In Study II, 46 out of the 65 enrolled patients (70%) were assessable. Out of these, three patients (7%) had CR, eight patients (17%) had PR, 10 patients (22%) had SD, and 25 (54%) PD. Overall response was 24% while an additional 22% showed stable disease. Toxicity mainly consisted of leucopenia and pain. CONCLUSION: Docetaxel as a single agent is active in esophageal cancer, both in treatment naive and in previously treated patients with recurrent disease. The overall response rate was 31%, with a good-safety profile. The addition of gemcitabine is well tolerated, but adds no efficacy. Weekly administration of docetaxel may be less effective. It demonstrates moderate efficacy and the doses used provide an acceptable safety profile.
|
|
| 6. |
- Georgantopoulos, Christos K., et al.
(författare)
-
Slip of styrene–butadiene rubbers: The effects of pressure and viscous heating.
- 2024
-
Ingår i: Physics of Fluids. - 1089-7666 .- 1070-6631. ; 36:1
-
Tidskriftsartikel (refereegranskat)abstract
- During the processing of elastomeric compounds under high flow rates, significant pressure drops (106–108 Pa) are encountered. Under such conditions, the viscosity of these compounds is significantly affected by pressure and viscous heating. Moreover, strong flow rates may cause these systems to slip at the wall, violating the classical no-slip boundary condition of fluid mechanics. To determine the slip velocity by the well-known Mooney method, the effects of pressure and viscous heating should be considered. In this work, an experimental methodology is developed to determine the slip velocity of styrene–butadiene compounds in capillary flow corrected for the effects of pressure and viscous heating. First, the temperature increase due to viscous heating is measured during the extrusion process and accounted for in correcting the experimental data to infer the slip velocity. Consequently, the corrected experimental data for the effects of pressure and viscous heating are used to calculate the slip velocity from the deviation of the linear viscoelastic behavior (deviation from the Cox–Merz rule). The Mooney method is also used to confirm the calculated slip velocity of the elastomeric compounds.
|
|
| 7. |
- Nygård, K., et al.
(författare)
-
ForMAX – a beamline for multiscale and multimodal structural characterization of hierarchical materials
- 2024
-
Ingår i: Journal of Synchrotron Radiation. - : International Union of Crystallography (IUCr). - 0909-0495 .- 1600-5775. ; 31:Pt 2, s. 363-377
-
Tidskriftsartikel (refereegranskat)abstract
- The ForMAX beamline at the MAX IV Laboratory provides multiscale and multimodal structural characterization of hierarchical materials in the nanometre to millimetre range by combining small- and wide-angle X-ray scattering with full-field microtomography. The modular design of the beamline is optimized for easy switching between different experimental modalities. The beamline has a special focus on the development of novel fibrous materials from forest resources, but it is also well suited for studies within, for example, food science and biomedical research.
|
|
